Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 29.06.2026 2 Acta Ophthalmol 1 Am J Hypertens 2 Am J Manag Care 1 Am J Ophthalmol 3 Biochem Biophys Res Commun 5 BMC Ophthalmol 3 BMC Pediatr 1 BMJ 1 Clin Chem 8 Diabet Med 7 Diabetes 14 Diabetes Care 9 Diabetes Obes Metab 6 Diabetologia 1 Invest Ophthalmol Vis Sci 1 J Clin Endocrinol Metab 1 J Diabetes Complications 1 J Hypertens 1 J Nutr 1 Lancet 1 Ophthalmol Retina 1 PLoS Med 9 PLoS One 2 Retina 1 Stroke

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. JEPPESEN SK, Bek T
   Visual acuity is reduced with increasing central retinal thickness, but also with higher age and female sex in diabetic macular oedema.
   Acta Ophthalmol. 2026 Jun 23. doi: 10.1111/aos.70177.
   PubMed         Abstract available
   
   
2. FEDOTKINA O, Begum MC, Trinh XT, Ozgumus T, et al
   Genome-wide association and interaction analysis for proliferative retinopathy in adults with type 2 diabetes born during famine: The DOLCE study in Ukraine.
   Acta Ophthalmol. 2026 Jun 25. doi: 10.1111/aos.70187.
   PubMed         Abstract available
   
   

   
   Am J Hypertens

3. JIANG J
   Competing Risk of Death and the Hypertension-Atrial Fibrillation Association in Diabetes.
   Am J Hypertens. 2026 Jun 19:hpag063. doi: 10.1093.
   PubMed        
   
   

   
   Am J Manag Care

4. OUEINI R, Shirley B, Teigland C, Castora-Binkley M, et al
   Changes in persistence to basal insulin following the Medicare out-of-pocket cost cap.
   Am J Manag Care. 2026;32:e212-e216.
   PubMed         Abstract available
   
   
5. SPITERY A, Lobkovich A, Thomas E
   Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.
   Am J Manag Care. 2026;32:328-333.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

6. ZHOU C, Shen Y, Li S, Li Y, et al
   Therapeutic response to anti-VEGF retreatment among eyes with stabilized vision after being lost to follow-up in diabetic macular edema: A nationwide, registry-based cohort study.
   Am J Ophthalmol. 2026 Jun 22:S0002-9394(26)00341.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

7. BAI B, Song Y, Tian L
   Exosome-like nanoparticles derived from Salvia miltiorrhiza promote diabetic wound healing by reducing oxidative stress and inflammation.
   Biochem Biophys Res Commun. 2026;829:154115.
   PubMed         Abstract available
   
   
8. KOOLABADI Z, Taghipour N, Rouhani M, Soleimani M, et al
   Formulation and characterization of 15d-PGJ2 loaded PLGA nanoparticles and in vitro evaluation of small intestinal submucosa integrated with nanoparticles for diabetic wound.
   Biochem Biophys Res Commun. 2026;829:153935.
   PubMed         Abstract available
   
   
9. WU Q, Hou D, Wang X, Fu Y, et al
   Allograft inflammatory factor-1 in macrophages promotes renal tubular cell epithelial-mesenchymal transition via the NF-kappaB/IL-1beta axis in diabetic kidney disease.
   Biochem Biophys Res Commun. 2026;829:154192.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

10. MA JB, Qin MZ, Cao K, Zhang YP, et al
    Effects of blood pressure and blood glucose levels on foveal avascular zone area.
    BMC Ophthalmol. 2025;26:35.
    PubMed         Abstract available
    
    
11. WANG Y, Li J, Lin Y, Hu W, et al
    The association between magnesium and diabetic retinopathy: a cross-sectional study.
    BMC Ophthalmol. 2026 Jun 22. doi: 10.1186/s12886-026-05020.
    PubMed         Abstract available
    
    
12. YANG Q, Zhang H, Ke Y, Li X, et al
    Circumferential quantitative analysis of iris angiography reveals progressive pupillary-margin leakage across stages of diabetic retinopathy.
    BMC Ophthalmol. 2026 Jun 25. doi: 10.1186/s12886-026-05073.
    PubMed         Abstract available
    
    
13. DENG A, Gan Y, Da J, Ning Q, et al
    Early dynamic response on spectral-domain OCT predicts long-term visual outcome in diabetic macular edema treated with aflibercept.
    BMC Ophthalmol. 2026 Jun 25. doi: 10.1186/s12886-026-05030.
    PubMed         Abstract available
    
    
14. CHEN H, Shang Y, Yang P, Zhou Y, et al
    Association of early anti-VEGF Therapy anatomical response with renal function and OCT biomarkers in diabetic macular edema.
    BMC Ophthalmol. 2026 Jun 26. doi: 10.1186/s12886-026-05047.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

15. GUAN Y, Xie J, Wang F, Ouyang Y, et al
    Application of gamified interventions in children with type 1 diabetes: a scoping review.
    BMC Pediatr. 2026 Jun 20. doi: 10.1186/s12887-026-07142.
    PubMed         Abstract available
    
    
16. RANAEI A, Lael-Monfared E, Peyman N
    The mediating role of self-care in the relationship between eHealth literacy and quality of life among adolescents with type 1 diabetes.
    BMC Pediatr. 2026 Jun 22. doi: 10.1186/s12887-026-07050.
    PubMed         Abstract available
    
    
17. FAWAZ L, Badawi N, Hasan M, Shamma R, et al
    Impact of telemonitoring on glycemic control and quality of life in pediatric patients with type 1 diabetes, single center interventional control study.
    BMC Pediatr. 2026;26:586.
    PubMed         Abstract available
    
    

    
    BMJ

18. WISE J
    Type 1 diabetes: Drug to delay onset approved for use in the NHS.
    BMJ. 2026;393:e100063.
    PubMed        
    
    

    
    Clin Chem

19. CAO T, Fang M, Wallace AS, Daya Malek N, et al
    Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.
    Clin Chem. 2026 Jun 25:hvag067. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Diabet Med

20. COCKCROFT EJ, Bright C, Nathan H, Farrow D, et al
    Barriers and enablers to physical activity in type 1 diabetes: A mixed-methods study of adults and parent-reported child perspectives in the UK.
    Diabet Med. 2026 Jun 19:e70378. doi: 10.1111/dme.70378.
    PubMed         Abstract available
    
    
21. RYGG MO, Moller AL, Curovic VR, Rasmussen DGK, et al
    Extracellular matrix proteins as risk markers for complications in type 1 diabetes.
    Diabet Med. 2026 Jun 20:e70396. doi: 10.1111/dme.70396.
    PubMed         Abstract available
    
    
22. GAVOYANNIS G, Turner J, Fox S, Mani H, et al
    Early-onset type 2 diabetes (EOT2D): A clinical review of classification leading to 10% reclassification.
    Diabet Med. 2026 Jun 25:e70409. doi: 10.1111/dme.70409.
    PubMed        
    
    
23. QIAN T, Guo D, Zhang M, Liu Y, et al
    Beyond HbA1c: A CGM-centred three-pillar framework for glycaemic variability in pre-diabetes and type 2 diabetes.
    Diabet Med. 2026 Jun 25:e70404. doi: 10.1111/dme.70404.
    PubMed         Abstract available
    
    
24. SUSHKO K, Sherifali D, Smith K, L Lipscombe L, et al
    Exploring women's preferences for diabetes prevention programs after gestational diabetes: A qualitative descriptive study.
    Diabet Med. 2026 Jun 25:e70397. doi: 10.1111/dme.70397.
    PubMed         Abstract available
    
    
25. GOLDING JA, Long SO, Hope SV, Wright JE, et al
    The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational study.
    Diabet Med. 2026 Jun 23:e70406. doi: 10.1111/dme.70406.
    PubMed         Abstract available
    
    
26. SYLEOUNI ME, Lee TTM, Carrieri F, Scott EM, et al
    HbA1c improvement in pregnant women with type 1 diabetes using the CamAPS FX automated insulin delivery (AID) system: Clinical and economic outcomes.
    Diabet Med. 2026 Jun 21:e70394. doi: 10.1111/dme.70394.
    PubMed         Abstract available
    
    
27. L'AMIE A, Vincent AL, Jefferies CA, Braatvedt G, et al
    Wolfram syndrome and diabetes mellitus in Aotearoa, New Zealand: Phenotype and response to GLP-1 receptor agonist therapy.
    Diabet Med. 2026 Jun 21:e70405. doi: 10.1111/dme.70405.
    PubMed         Abstract available
    
    

    
    Diabetes

28. SAKAKI K, Murakami T, Yabe D, Inagaki N, et al
    Response to Comment on Sakaki et al. Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
    Diabetes. 2026;75:e23-e24.
    PubMed        
    
    
29. PAGE B
    Diabetes Spotlight: Rana Gupta, PhD-Developmental Biology and Adipose Tissue.
    Diabetes. 2026;75:1051.
    PubMed        
    
    
30. VAZQUEZ ARREOLA E, Knowler WC, Hanson RL
    Global and Partitioned Polygenic Risk Scores: Associations With Pathophysiology and Incidence of Type 2 Diabetes in People With Prediabetes.
    Diabetes. 2026;75:1329-1337.
    PubMed         Abstract available
    
    
31. DARDARI D
    Glycemic Improvement and Active Charcot Neuroarthropathy: Osteocalcin as a Candidate Biomarker of Transient Skeletal Vulnerability.
    Diabetes. 2026;75:1067-1070.
    PubMed         Abstract available
    
    
32. SAINT-MARTIN C, ElSheikh A, Jacqueminet S, Arnoux JB, et al
    Co-occurrence of Loss-of-Function GCK and ABCC8 Variants in a Pedigree With a Spectrum of Dysglycemia.
    Diabetes. 2026;75:1323-1328.
    PubMed         Abstract available
    
    
33. LI S, Wang J, Xin C, Dong Y, et al
    beta-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A.
    Diabetes. 2026;75:1125-1141.
    PubMed         Abstract available
    
    
34. HOU Y, Chen T, Zhou J, Guo Z, et al
    The Mechanism of TNF-alpha Combined With High Glucose in Regulating Calnexin Aggravates Endoplasmic Reticulum Stress in Endothelial Cell Injury of Diabetic Retinopathy.
    Diabetes. 2026;75:1150-1161.
    PubMed         Abstract available
    
    

    
    Diabetes Care

35. MAAGENSEN H, Hoyerup SO, Jensen JS, Thuesen ACB, et al
    Empagliflozin in HNF1A-MODY (MODY3): A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Diabetes Care. 2026;49:1166-1174.
    PubMed         Abstract available
    
    
36. ESPELAND MA, Semelka CT, Kritchevsky SB, Evans JK, et al
    The Look AHEAD Research Program: A 25-Year Retrospective From the Perspective of Geroscience.
    Diabetes Care. 2026;49:1159-1162.
    PubMed         Abstract available
    
    
37. HANDELSMAN Y, Fonseca V, Buse JB, Auchus RJ, et al
    Comment on Nieman and Muniyappa Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?
    Diabetes Care. 2026;49:e131-e132.
    PubMed        
    
    
38. LI B, Han D
    Comment on Bragg et al. Metabolomic Profile of Genetic Liability to Type 2 Diabetes Among 125,000 Mexican Adults: A Mendelian Randomization Study.
    Diabetes Care. 2026;49:e134-e135.
    PubMed        
    
    
39. LAMOTHE S, Bourcigaux N, Vatier C, Christin-Maitre S, et al
    Comment on Korakas et al. 780G Hybrid Closed-Loop Pump as Adjunct to Metreleptin in Lipodystrophy-Associated Diabetes: Three Case Observations.
    Diabetes Care. 2026;49:e136-e137.
    PubMed        
    
    
40. ROONEY MR, Echouffo Tcheugui JB, Chen J, Walker KA, et al
    Proteomic Signatures of 3-Year Progression From Impaired Fasting Glucose to Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetes Care. 2026 Jun 25:dc260498. doi: 10.2337/dc26-0498.
    PubMed         Abstract available
    
    
41. QIAN J, Stefanovski D, Andersen PAK, Vujovic N, et al
    Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant.
    Diabetes Care. 2026 Jun 25:dc260164. doi: 10.2337/dc26-0164.
    PubMed         Abstract available
    
    
42. GALINDO RJ, Moazzami B, Gerges A, Flores I, et al
    Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.
    Diabetes Care. 2026 Jun 26:dc260404. doi: 10.2337/dc26-0404.
    PubMed         Abstract available
    
    
43. AHMED M, Kubota-Mishra E, Siller AF, Davis A, et al
    A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.
    Diabetes Care. 2026 Jun 26:dc260464. doi: 10.2337/dc26-0464.
    PubMed         Abstract available
    
    
44. HENNEKES MHCL, Haugvik S, Wit M, Toschi E, et al
    Erratum. Diabetes Body Project: Acute Effects of an Eating Disorder Prevention Program for Young Women With Type 1 Diabetes. A Multinational Randomized Controlled Trial. Diabetes Care 2025;48:220-225.
    Diabetes Care. 2026 Jun 23:dc26er09a. doi: 10.2337.
    PubMed         Abstract available
    
    
45. LESLIE RD, Zhou Z, Pozzilli P
    Characteristic Traits of Type 1 Diabetes by Age at Presentation Go Over the Rainbow.
    Diabetes Care. 2026;49:1163-1165.
    PubMed        
    
    
46. YANG W, Li M
    Comment on Yu et al. Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes.
    Diabetes Care. 2026;49:e133.
    PubMed        
    
    
47. CAO YT, Zhou XQ
    Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.
    Diabetes Care. 2026;49:e127-e128.
    PubMed        
    
    
48. HUTTASCH M, Roden M
    Response to Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.
    Diabetes Care. 2026;49:e129-e130.
    PubMed        
    
    

    
    Diabetes Obes Metab

49. ABDULSALAM R, Jebb SA, Michalopoulou M, Piernas C, et al
    Postpartum Body Weight and Cardiometabolic Biomarker Trajectories in Women With Gestational Diabetes: A Population-Based Matched Cohort Study.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.70994.
    PubMed         Abstract available
    
    
50. XIAO Q, Zheng Y, Zhao H, Li Y, et al
    Large-Scale Proteomics Uncovers Pre-Disease Inflammation-Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.71038.
    PubMed         Abstract available
    
    
51. ARTEAGA-DIAZ JM, Torres-Grajales JL, Sauque-Reyna L, Salamanca-Carrillo C, et al
    Real-World Effectiveness and Safety of iGlarLixi in People With Type 2 Diabetes in LATAM Region: A Subanalysis of the SUCCESS Study.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.71018.
    PubMed        
    
    
52. EKINCI EI, Maldonado SG, Unseld A, Martinez JA, et al
    Dual Glucagon and GLP-1 Receptor Agonist Survodutide Improves Biomarkers of Beta-Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.70861.
    PubMed         Abstract available
    
    
53. MAIER GA, Hofmann RA, Roden M, Rathmann W, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.71023.
    PubMed         Abstract available
    
    
54. WHARTON S, Stefanski A, Chen J, Rao G, et al
    Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials.
    Diabetes Obes Metab. 2026 Jun 23. doi: 10.1111/dom.71032.
    PubMed         Abstract available
    
    
55. LIN YK, Soholm U, Ratzki-Leewing A, Ye W, et al
    The Impact of Hypoglycaemia on Quality of Life in Adults With Type 1 Diabetes Using Contemporary Diabetes Technologies: A US National Survey.
    Diabetes Obes Metab. 2026 Jun 25. doi: 10.1111/dom.71028.
    PubMed         Abstract available
    
    
56. LI X, Ye X, Tang J, Wang Q, et al
    Glycaemic Control During School Days and Holidays in Children and Adolescents With Type 1 Diabetes Using Open-Source Android Artificial Pancreas Systems: A Real-World Study.
    Diabetes Obes Metab. 2026 Jun 25. doi: 10.1111/dom.70970.
    PubMed         Abstract available
    
    
57. PARK S, Jung J, Jeong J, Jang MH, et al
    Cardiorenal Outcomes of Empagliflozin Versus Dapagliflozin in Secondary Prevention Among Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study.
    Diabetes Obes Metab. 2026 Jun 25. doi: 10.1111/dom.71042.
    PubMed        
    
    

    
    Diabetologia

58. MCCARTHY A, Kent G, Thomas J, Martine-Edith G, et al
    Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study.
    Diabetologia. 2026 Jun 20. doi: 10.1007/s00125-026-06775.
    PubMed         Abstract available
    
    
59. MOHAN V
    Impacting lives of people with diabetes: lessons learnt in India may be applicable to other low- and middle-income countries.
    Diabetologia. 2026 Jun 23. doi: 10.1007/s00125-026-06776.
    PubMed         Abstract available
    
    
60. MATEJKO B, Cyranka K, Sudul P, Susul K, et al
    Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults >/=65 years with type 1 diabetes: a randomised, single-centre study.
    Diabetologia. 2026 Jun 25. doi: 10.1007/s00125-026-06780.
    PubMed         Abstract available
    
    
61. YILMAZ UC, Kizilay DO, Kurt OK, Balaban Berber IB, et al
    Autoantibody screening in children who are first-degree relatives of individuals with type 1 diabetes in a sibling-dominant cohort in Turkey: a multicentre study on prevalence, determinants and post-screening parent-child anxiety.
    Diabetologia. 2026 Jun 25. doi: 10.1007/s00125-026-06783.
    PubMed         Abstract available
    
    
62. MADDALONI E, Pezzica S, Amendolara R, Sabatini S, et al
    Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.
    Diabetologia. 2026 Jun 26. doi: 10.1007/s00125-026-06777.
    PubMed         Abstract available
    
    
63. SAID N, Jones I, Anderson-Baucum EK, Evans-Molina C, et al
    SARS-CoV-2 and diabetes: a post-pandemic reappraisal.
    Diabetologia. 2026 Jun 27. doi: 10.1007/s00125-026-06785.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

64. GUO Z, Li X, Chen X, Ma X, et al
    Senp1 O-GlcNAcylation Promotes Mitochondrial Fragmentation by Regulating Fis1 SUMO1-ylation Underlying Diabetic Cataract.
    Invest Ophthalmol Vis Sci. 2026;67:44.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

65. COHEN A, Karmi O, Abdulhag UN, Klopstock T, et al
    Reversible Mitochondrial Iron Toxicity in Wolfram Syndrome Type 2 Monogenic Diabetes.
    J Clin Endocrinol Metab. 2026 Jun 24:dgag250. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

66. MAYYAS F
    Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes.
    J Diabetes Complications. 2026;40:109362.
    PubMed         Abstract available
    
    

    
    J Hypertens

67. SETJIADI D, Delles C, Kroon AA, Ressink K, et al
    Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study.
    J Hypertens. 2026 Feb 16. doi: 10.1097/HJH.0000000000004265.
    PubMed         Abstract available
    
    

    
    J Nutr

68. FRANKENFELD CL, Movva N, Hooda N, Gauthier J, et al
    Analysis of National Health and Nutrition Examination Survey (NHANES): Nutrient, food, and beverage intake of GLP1-RA users with Type 2 Diabetes, 2007-2020.
    J Nutr. 2026 Jun 22:101685. doi: 10.1016/j.tjnut.2026.101685.
    PubMed         Abstract available
    
    

    
    Lancet

69. KHUNTI K, Zaccardi F, Mehta R, Gregg EW, et al
    Epidemiology of cardiometabolic multiple long-term conditions.
    Lancet. 2026;407:2641-2654.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

70. MUAYAD J, Butt FR, Loya A, Chauhan MZ, et al
    Systemic Anemia and the Risk of Diabetic Macular Edema and Anti-VEGF Injections.
    Ophthalmol Retina. 2026 Jun 26:S2468-6530(26)00314.
    PubMed         Abstract available
    
    

    
    PLoS Med

71. CHAN L, Xu W, Chan EWY, Wan EYF, et al
    Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.
    PLoS Med. 2026;23:e1005136.
    PubMed         Abstract available
    
    

    
    PLoS One

72. HUANG L, Wang TM, Sugimoto JD, Heberer KR, et al
    Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort.
    PLoS One. 2026;21:e0351992.
    PubMed         Abstract available
    
    
73. BHASIN G, Dafale RS, Kamath SU, Prabhu MM, et al
    Comparative performance of invasive, semi-invasive, and non-invasive insulin resistance-related indices across prediabetes and normoglycemia.
    PLoS One. 2026;21:e0351950.
    PubMed         Abstract available
    
    
74. PROBANDARI A, Modesty K, Tjung V, Sitepu BE, et al
    Potentials, barriers, and strategies for integrating tuberculosis, diabetes mellitus, and hypertension case management: A scoping review.
    PLoS One. 2026;21:e0345708.
    PubMed         Abstract available
    
    
75. RAVINDRARAJAH R, Gittins M, Paterson L, Rogers G, et al
    Clinical and cost-effectiveness of the digital intervention, MyWay Diabetes, in people with type 2 diabetes living in Greater Manchester during the COVID-19 pandemic.
    PLoS One. 2026;21:e0349232.
    PubMed         Abstract available
    
    
76. LIU M, Song H, Zhang C, Li J, et al
    Bioinformatics analysis of pyroptosis-related differentially expressed genes in sepsis and diabetes mellitus.
    PLoS One. 2026;21:e0352310.
    PubMed         Abstract available
    
    
77. OH S, Kim S, Yun J, Min JK, et al
    Family history of diabetes and glycemic progression: A propensity score-based analysis using health checkup data.
    PLoS One. 2026;21:e0352348.
    PubMed         Abstract available
    
    
78. LI Y, Zou Z, Yi S, Yang Y, et al
    An intervention study of the general practice management of older adults with cardiovascular metabolic comorbidities.
    PLoS One. 2026;21:e0350895.
    PubMed         Abstract available
    
    
79. RAMPAL S, Lopes CA, Hadi P, Neela VK, et al
    Risk factors associated with diabetic foot amputation: A retrospective study from a tertiary hospital in Central Malaysia.
    PLoS One. 2026;21:e0335328.
    PubMed         Abstract available
    
    
80. CHHAM S, Ir P, Olmen JV, Buffel V, et al
    Exploring the potential of community health workers in type-2 diabetes and hypertension management in Cambodia.
    PLoS One. 2026;21:e0351958.
    PubMed         Abstract available
    
    

    
    Retina

81. LI B, Li S, Cun Y
    THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.
    Retina. 2026 Apr 28. doi: 10.1097/IAE.0000000000004869.
    PubMed        
    
    
82. TORRES-VILLAROS H, Lachiver L, Fajnkuchen F, Morel JB, et al
    Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.
    Retina. 2026 Jun 23. doi: 10.1097/IAE.0000000000004912.
    PubMed         Abstract available
    
    

    
    Stroke

83. LU L, Yang B, Wang Y, Zhu C, et al
    Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial.
    Stroke. 2026 May 18. doi: 10.1161/STROKEAHA.125.056010.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum